20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Accelerate Diagnostics Inc (NASDAQ: AXDX), an in-vitro diagnostics company providing solutions to improve patient outcomes and lower healthcare costs, was one of Wall Street's top performing stocks on Friday.
Shares of Accelerate Diagnostics opened for trading at $14.28 and hit an intra-day high of $15.70. By mid-afternoon, the stock was trading at $15.08, up 6.35 percent on the day.
Accelerate Diagnostics announced earlier in the morning that the U.S. District Court for the District of Arizona granted the company's "Motion to Dismiss" a class action lawsuit filed against it in March, 2015.
Related Link: Looking To Healthcare ETFs For Earnings Growth
A class action suit from shareholders alleged Accelerate Diagnostics's management intentionally misled investors regarding the capabilities of its rapid diagnostic platform.,/p>
By granting the motion, the court ordered that the action be dismissed with prejudice in its entirety.
Steve Schatz of Wilson Sonsini represented Accelerate Diagnostics and stated, "This was a case that should never have been brought and was utterly without merit. The Judge clearly did the right thing."
Image Credit: Public Domain20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine." A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!